Flawless Pharma signs API deals with European CDMO and African company for $120 million
To supply APIs for anti-cancer and anti-viral drugs with a technology transfer agreement
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Venus Remedies launches Elores in Ecuador
Elores, an antibiotic formulation has been developed to combat multi-drug-resistant infections
Healthcare industry reported 53 deals worth $4.3 billion in September 2023
Deal value decreased by 48.2 per cent in September 2023, compared to September 2022
Ichnos Sciences signs licensing pact with Astria Therapeutics for OX40 antagonist monoclonal…
Astria Therapeutics is granted global rights to develop and commercialise OX40 portfolio, comprised of Telazorlimab and its…
AstraZeneca’s Tagrisso to lead lung cancer small molecule market with over $7 bn sales by 2029:…
GlobalData reveals that a total of 39 small molecules have been commercialised for the treatment of lung cancer, with a total of…
Alvotech’s AVT05 emerges as leading contender for Simponi biosimilar in rheumatoid arthritis:…
In May 2023, Alvotech and Advanz Pharma announced an extended strategic partnership with plans to supply and commercialise five…
Cadila Pharma launches under eye cream
The Cahaya Naturals Under Eye Cream is formulated with L-Glutathione, Vitamin C and other natural extracts that are rich in…
Patient comfort in AI-driven healthcare linked to familiarity: GlobalData
GlobalData’s recent survey*, “Thematic Intelligence: AI in Clinical Practice – Patient Perspective 2023,” reveals that out of…
Your right to play in this market requires a degree of sophistication, automation
Blue Star Engineering & Electronics recently announced a partnership with Gebhardt Intralogistics Group of Germany, for…
Biocon signs commercialisation pact with Juno Pharma in Canada for Liraglutide
Liraglutide is a drug-device combination for the treatment and management of Type 2 diabetes and obesity
Zydus gets USFDA nod for Sugammadex Injection, 200 mg/2 mL and 500 mg/5 mL single-dose vial
Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide…
US FDA accepts Sun Pharma’s NDA for Deuruxolitinib
Deuruxolitinib is being evaluated for treatment of moderate to severe alopecia areata
Ashoka University wins Innovation Award for AMR Data Challenge
The award was presented for their contribution, titled “Novel Approach to Antibiogram Analysis: Looking at the Composite…
Strides gets USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate…
Strides’ ANDA is approved under USFDA’s expedited review provision for the President’s Emergency Plan for AIDS Relief (PEPFAR)
Alembic Pharma gets six USFDA approvals in Q2FY24
Approvals include Chlorpromazine Hydrochloride Tablets USP, Brimonidine Tartrate Ophthalmic Solution, Guanfacine Extended-Release…
Insomnia treatment market faces need for innovation: GlobalData
Z-drugs have dominated the insomnia pharmacological treatment market for the past 30 years. However, due to their unfavorable side…
Strides gets USFDA approval for Icosapent Ethyl Capsules
The product complements Strides’ range of approved soft gelatin capsules
Novo Nordisk Wegovy’s NHS access marks milestone in obesity treatment, but challenges remain:…
The constrained supply of Wegovy and the necessity of ongoing obesity management support are key considerations
Marksans Pharma gets US FDA nod for Esomeprazole Magnesium DR Capsules USP, 20 mg (OTC)
Esomeprazole is used to treat certain stomach and esophagus problems such as acid reflux and ulcer
Sun Pharma Canada launches WINLEVI for acne
WINLEVI is the first and only topical androgen receptor inhibitor